509 related articles for article (PubMed ID: 10891427)
1. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.
Salcedo R; Ponce ML; Young HA; Wasserman K; Ward JM; Kleinman HK; Oppenheim JJ; Murphy WJ
Blood; 2000 Jul; 96(1):34-40. PubMed ID: 10891427
[TBL] [Abstract][Full Text] [Related]
2. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells.
Salcedo R; Young HA; Ponce ML; Ward JM; Kleinman HK; Murphy WJ; Oppenheim JJ
J Immunol; 2001 Jun; 166(12):7571-8. PubMed ID: 11390513
[TBL] [Abstract][Full Text] [Related]
3. I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo.
Bernardini G; Spinetti G; Ribatti D; Camarda G; Morbidelli L; Ziche M; Santoni A; Capogrossi MC; Napolitano M
Blood; 2000 Dec; 96(13):4039-45. PubMed ID: 11110671
[TBL] [Abstract][Full Text] [Related]
4. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.
Ribatti D; Presta M; Vacca A; Ria R; Giuliani R; Dell'Era P; Nico B; Roncali L; Dammacco F
Blood; 1999 Apr; 93(8):2627-36. PubMed ID: 10194442
[TBL] [Abstract][Full Text] [Related]
5. Expression of CCR2 by endothelial cells : implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium.
Weber KS; Nelson PJ; Gröne HJ; Weber C
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2085-93. PubMed ID: 10479649
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center.
Hotchkiss KA; Ashton AW; Mahmood R; Russell RG; Sparano JA; Schwartz EL
Mol Cancer Ther; 2002 Nov; 1(13):1191-200. PubMed ID: 12479700
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
[TBL] [Abstract][Full Text] [Related]
8. The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo.
Liu JM; Lawrence F; Kovacevic M; Bignon J; Papadimitriou E; Lallemand JY; Katsoris P; Potier P; Fromes Y; Wdzieczak-Bakala J
Blood; 2003 Apr; 101(8):3014-20. PubMed ID: 12480715
[TBL] [Abstract][Full Text] [Related]
9. Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis.
Ali S; Palmer AC; Fritchley SJ; Maley Y; Kirby JA
Biochem J; 2001 Sep; 358(Pt 3):737-45. PubMed ID: 11535134
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
[TBL] [Abstract][Full Text] [Related]
11. Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis.
Volin MV; Woods JM; Amin MA; Connors MA; Harlow LA; Koch AE
Am J Pathol; 2001 Oct; 159(4):1521-30. PubMed ID: 11583978
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo.
Hwang J; Kim CW; Son KN; Han KY; Lee KH; Kleinman HK; Ko J; Na DS; Kwon BS; Gho YS; Kim J
FEBS Lett; 2004 Jul; 570(1-3):47-51. PubMed ID: 15251437
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models.
Lee MS; Moon EJ; Lee SW; Kim MS; Kim KW; Kim YJ
Cancer Res; 2001 Apr; 61(8):3290-3. PubMed ID: 11309282
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis and tumour growth by VEGF121-toxin conjugate: differential effect on proliferating endothelial cells.
Wild R; Dhanabal M; Olson TA; Ramakrishnan S
Br J Cancer; 2000 Oct; 83(8):1077-83. PubMed ID: 10993657
[TBL] [Abstract][Full Text] [Related]
15. Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1.
Wang S; Xu M; Li F; Wang X; Bower KA; Frank JA; Lu Y; Chen G; Zhang Z; Ke Z; Shi X; Luo J
Breast Cancer Res Treat; 2012 Jun; 133(3):1037-48. PubMed ID: 22160640
[TBL] [Abstract][Full Text] [Related]
16. Rat aortic MCP-1 and its receptor CCR2 increase with age and alter vascular smooth muscle cell function.
Spinetti G; Wang M; Monticone R; Zhang J; Zhao D; Lakatta EG
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1397-402. PubMed ID: 15178559
[TBL] [Abstract][Full Text] [Related]
17. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor.
Hetian L; Ping A; Shumei S; Xiaoying L; Luowen H; Jian W; Lin M; Meisheng L; Junshan Y; Chengchao S
J Biol Chem; 2002 Nov; 277(45):43137-42. PubMed ID: 12183450
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.
Seon BK; Matsuno F; Haruta Y; Kondo M; Barcos M
Clin Cancer Res; 1997 Jul; 3(7):1031-44. PubMed ID: 9815781
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.
Salcedo R; Wasserman K; Young HA; Grimm MC; Howard OM; Anver MR; Kleinman HK; Murphy WJ; Oppenheim JJ
Am J Pathol; 1999 Apr; 154(4):1125-35. PubMed ID: 10233851
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the angiogenesis by the MCP-1 (monocyte chemoattractant protein-1) binding peptide.
Kim MY; Byeon CW; Hong KH; Han KH; Jeong S
FEBS Lett; 2005 Mar; 579(7):1597-601. PubMed ID: 15757647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
